Randomized phase II – study evaluating EGFR targeting therapy with Cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer...

por Krempien, R, Muenter, MW, Huber, PE, Nill, S, Friess, H, Timke, C, Didinger, B, Buechler, P, Heeger, S, Herfarth, KK, Abdollahi, A, Buchler, MW, Debus, J
Publicado 2005